Exelixis
EXEL
#1683
Rank
S$13.60 B
Marketcap
$47.65
Share price
1.44%
Change (1 day)
67.84%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company